14 febbraio 2022 – Up to 8 February 2022, Swissmedic evaluated 12,334 reports on suspected adverse drug reactions. 62 % were reported to Swissmedic as “not serious”, while 38 % were classified as “serious”. The majority of the reports involved more than one reaction. The overall positive benefit-risk ratio of the vaccines remains.

For more information, see here.